| Dec 7, 2025 |
Dec 9, 2025 |
OmniAb, Inc.
|
CEO |
Sell |
51.3
|
-13,666
|
-0.31%
|
✗
|
$26.8K |
| Apr 7, 2025 |
Apr 7, 2025 |
OmniAb, Inc.
|
CEO |
Sell |
48.8
|
-19,382
|
-0.51%
|
✗
|
$38.8K |
| Feb 15, 2025 |
Feb 19, 2025 |
OmniAb, Inc.
|
CEO |
Sell |
45.0
|
-33,486
|
-0.88%
|
✗
|
$123K |
| Jan 17, 2025 |
Jan 22, 2025 |
OmniAb, Inc.
|
CEO |
Sell |
72.5
|
+35,192
|
0.95%
|
✗
|
$135.5K |
| Dec 7, 2024 |
Dec 10, 2024 |
OmniAb, Inc.
|
CEO |
Sell |
47.5
|
-13,634
|
-0.37%
|
✗
|
$56.3K |
| May 24, 2024 |
May 28, 2024 |
OmniAb, Inc.
|
CEO |
Buy |
95.0
|
+240,000
|
7.28%
|
✗
|
$1.1M |
| Apr 7, 2024 |
Apr 9, 2024 |
OmniAb, Inc.
|
CEO |
Sell |
45.0
|
-18,477
|
-0.58%
|
✗
|
$98.1K |
| Mar 22, 2024 |
Mar 25, 2024 |
OmniAb, Inc.
|
CEO |
Buy |
95.0
|
+225,000
|
8.38%
|
✗
|
$1.2M |
| Feb 15, 2024 |
Feb 20, 2024 |
OmniAb, Inc.
|
CEO |
Sell |
47.5
|
-18,919
|
-0.35%
|
✗
|
$104.8K |
| Jan 2, 2024 |
Jan 3, 2024 |
OmniAb, Inc.
|
CEO |
Sell |
47.5
|
-13,221
|
-0.49%
|
✗
|
$82.6K |
| Dec 12, 2023 |
Dec 13, 2023 |
OmniAb, Inc.
|
CEO |
Buy |
95.0
|
+200,000
|
8.18%
|
✗
|
$1M |
| Dec 7, 2023 |
Dec 11, 2023 |
OmniAb, Inc.
|
CEO |
Sell |
51.3
|
-9,184
|
-0.37%
|
✗
|
$44.5K |
| Nov 10, 2023 |
Nov 13, 2023 |
OmniAb, Inc.
|
CEO |
Buy |
90.0
|
+95,000
|
4.07%
|
✗
|
$405.5K |
| Aug 14, 2023 |
Aug 15, 2023 |
OmniAb, Inc.
|
CEO |
Buy |
82.5
|
+45,000
|
1.97%
|
✗
|
$246.6K |
| Jun 9, 2023 |
Jun 12, 2023 |
OmniAb, Inc.
|
CEO |
Buy |
90.0
|
+115,000
|
4.68%
|
✗
|
$519.8K |
| May 12, 2023 |
May 15, 2023 |
OmniAb, Inc.
|
CEO |
Buy |
100.0
|
+440,000
|
22.02%
|
✗
|
$1.5M |
| Feb 15, 2023 |
Feb 17, 2023 |
OmniAb, Inc.
|
CEO |
Sell |
45.0
|
-17,086
|
-0.90%
|
✗
|
$64.9K |
| Dec 28, 2022 |
Dec 30, 2022 |
OmniAb, Inc.
|
CEO |
Sell |
36.3
|
-11,624
|
-0.63%
|
✗
|
$42.5K |
| Dec 12, 2022 |
Dec 14, 2022 |
OmniAb, Inc.
|
CEO |
Buy |
92.5
|
+150,000
|
8.89%
|
✗
|
$564.8K |
| Dec 1, 2022 |
Dec 5, 2022 |
OmniAb, Inc.
|
CEO |
Sell |
22.5
|
-17,266
|
-1.01%
|
✗
|
$57.8K |
| Nov 30, 2022 |
Dec 1, 2022 |
OmniAb, Inc.
|
CEO |
Buy |
100.0
|
+300,000
|
21.35%
|
✗
|
$1M |
| Nov 9, 2022 |
Nov 9, 2022 |
OmniAb, Inc.
|
CEO |
Buy |
92.5
|
+100,000
|
7.66%
|
✗
|
$276.2K |
| May 13, 2022 |
May 13, 2022 |
LIGAND PHARMACEUTICALS INC
|
COO |
Buy |
82.5
|
+2,500
|
1.46%
|
✗
|
$206.9K |
| May 2, 2022 |
May 3, 2022 |
Viking Therapeutics, Inc.
|
Director |
Buy |
95.0
|
+45,000
|
67.92%
|
✗
|
$111.2K |
| Feb 15, 2022 |
Feb 16, 2022 |
LIGAND PHARMACEUTICALS INC
|
COO |
Sell |
40.0
|
-3,546
|
-2.03%
|
✗
|
$438.6K |
| Jan 26, 2022 |
Jan 28, 2022 |
LIGAND PHARMACEUTICALS INC
|
COO |
Sell |
90.0
|
+7,875
|
4.73%
|
✗
|
$582.6K |
| Nov 11, 2021 |
Nov 12, 2021 |
LIGAND PHARMACEUTICALS INC
|
COO |
Sell |
17.5
|
-11,160
|
-6.28%
|
✗
|
$1.8M |
| Aug 4, 2021 |
Aug 5, 2021 |
LIGAND PHARMACEUTICALS INC
|
COO |
Sell |
20.0
|
-8,840
|
-5.10%
|
✗
|
$969.5K |
| Jun 10, 2021 |
Jun 10, 2021 |
Viking Therapeutics, Inc.
|
Director |
Buy |
95.0
|
+20,000
|
43.24%
|
✗
|
$113.8K |
| Feb 15, 2021 |
Feb 18, 2021 |
LIGAND PHARMACEUTICALS INC
|
COO |
Sell |
40.0
|
-3,098
|
-1.84%
|
✗
|
$534.3K |
| Feb 3, 2021 |
Feb 5, 2021 |
LIGAND PHARMACEUTICALS INC
|
COO |
Sell |
16.3
|
-37,952
|
-10.17%
|
✗
|
$7.9M |
| Jan 25, 2021 |
Jan 27, 2021 |
LIGAND PHARMACEUTICALS INC
|
COO |
Sell |
90.0
|
+5,190
|
3.34%
|
✗
|
$518.7K |
| Aug 21, 2020 |
Aug 25, 2020 |
LIGAND PHARMACEUTICALS INC
|
COO |
Sell |
38.8
|
-7,303
|
-2.30%
|
✓
|
$824.2K |
| Jun 30, 2020 |
Jun 30, 2020 |
Viking Therapeutics, Inc.
|
Director |
Sell |
22.5
|
-13,000
|
-33.12%
|
✗
|
$95.6K |
| Feb 15, 2019 |
Apr 24, 2020 |
LIGAND PHARMACEUTICALS INC
|
COO |
Sell |
40.0
|
-2,826
|
-2.25%
|
✗
|
$341.6K |
| Feb 27, 2020 |
Feb 27, 2020 |
LIGAND PHARMACEUTICALS INC
|
COO |
Sell |
35.0
|
-7,225
|
-4.49%
|
✓
|
$794.8K |
| Feb 13, 2020 |
Feb 18, 2020 |
LIGAND PHARMACEUTICALS INC
|
COO |
Sell |
46.3
|
-2,315
|
-0.30%
|
✓
|
$934.2K |
| Dec 20, 2019 |
Dec 26, 2019 |
LIGAND PHARMACEUTICALS INC
|
COO |
Sell |
90.0
|
+3,717
|
2.57%
|
✗
|
$386.8K |
| Jan 23, 2019 |
Jan 25, 2019 |
LIGAND PHARMACEUTICALS INC
|
COO |
Sell |
90.0
|
+4,694
|
4.14%
|
✗
|
$287.1K |
| Oct 1, 2018 |
Oct 2, 2018 |
LIGAND PHARMACEUTICALS INC
|
COO |
Sell |
20.0
|
-12,000
|
-10.22%
|
✓
|
$3.3M |
| Aug 17, 2018 |
Sep 19, 2018 |
Qualigen Therapeutics, Inc.
|
Director |
Buy |
91.3
|
+19,751
|
564.31%
|
✗
|
$40.3K |
| Sep 4, 2018 |
Sep 5, 2018 |
LIGAND PHARMACEUTICALS INC
|
COO |
Sell |
20.0
|
-12,000
|
-10.41%
|
✓
|
$3.1M |
| Aug 17, 2018 |
Aug 20, 2018 |
Qualigen Therapeutics, Inc.
|
Director |
Buy |
91.3
|
+19,751
|
56.43%
|
✗
|
$40.3K |
| May 10, 2018 |
May 11, 2018 |
LIGAND PHARMACEUTICALS INC
|
COO |
Sell |
17.5
|
-8,881
|
-8.07%
|
✗
|
$1.5M |
| Mar 2, 2018 |
Mar 6, 2018 |
LIGAND PHARMACEUTICALS INC
|
COO |
Sell |
90.0
|
+5,366
|
5.60%
|
✗
|
$241.7K |
| Feb 23, 2018 |
Feb 27, 2018 |
LIGAND PHARMACEUTICALS INC
|
COO |
Sell |
20.0
|
-5,444
|
-5.38%
|
✗
|
$832.8K |
| Feb 15, 2018 |
Feb 16, 2018 |
LIGAND PHARMACEUTICALS INC
|
COO |
Sell |
40.0
|
-3,663
|
-3.72%
|
✗
|
$575.8K |
| Dec 28, 2017 |
Dec 29, 2017 |
LIGAND PHARMACEUTICALS INC
|
COO |
Sell |
90.0
|
+2,724
|
2.84%
|
✗
|
$412K |
| Aug 9, 2017 |
Aug 10, 2017 |
LIGAND PHARMACEUTICALS INC
|
COO |
Sell |
20.0
|
-6,100
|
-6.04%
|
✗
|
$777.8K |
| May 18, 2017 |
May 18, 2017 |
Qualigen Therapeutics, Inc.
|
Director |
Buy |
91.3
|
+18,000
|
105.88%
|
✗
|
$11.2K |
| May 12, 2017 |
May 15, 2017 |
LIGAND PHARMACEUTICALS INC
|
COO |
Sell |
20.0
|
-5,621
|
-5.72%
|
✗
|
$630.7K |
| Mar 2, 2017 |
Mar 3, 2017 |
LIGAND PHARMACEUTICALS INC
|
COO |
Sell |
20.0
|
-6,879
|
-7.05%
|
✗
|
$711.2K |
| Feb 15, 2017 |
Feb 28, 2017 |
LIGAND PHARMACEUTICALS INC
|
COO |
Sell |
92.5
|
+7,683
|
9.25%
|
✗
|
$521.2K |
| Nov 15, 2016 |
Nov 15, 2016 |
Viking Therapeutics, Inc.
|
Director |
Buy |
91.3
|
+13,000
|
49.52%
|
✗
|
$15.7K |
| Aug 5, 2016 |
Aug 9, 2016 |
LIGAND PHARMACEUTICALS INC
|
COO |
Sell |
17.5
|
-12,500
|
-13.67%
|
✗
|
$1.5M |
| Apr 13, 2016 |
Apr 13, 2016 |
Viking Therapeutics, Inc.
|
Director |
Buy |
91.3
|
+20,000
|
320.00%
|
✗
|
$24.8K |
| Mar 17, 2016 |
Mar 17, 2016 |
LIGAND PHARMACEUTICALS INC
|
COO |
Sell |
20.0
|
-6,400
|
-7.71%
|
✗
|
$618.9K |
| Feb 11, 2016 |
Feb 16, 2016 |
LIGAND PHARMACEUTICALS INC
|
COO |
Sell |
90.0
|
+4,034
|
5.55%
|
✗
|
$141.2K |
| Jan 8, 2016 |
Jan 11, 2016 |
Qualigen Therapeutics, Inc.
|
Director |
Buy |
91.3
|
+13,000
|
325.00%
|
✗
|
$21.3K |
| Jun 26, 2015 |
Jun 30, 2015 |
LIGAND PHARMACEUTICALS INC
|
COO |
Sell |
15.0
|
-12,500
|
-15.13%
|
✓
|
$1.3M |
| Jun 24, 2015 |
Jun 25, 2015 |
Qualigen Therapeutics, Inc.
|
Director |
Buy |
91.3
|
+4,000
|
100.00%
|
✗
|
$20K |
| Jun 22, 2015 |
Jun 24, 2015 |
LIGAND PHARMACEUTICALS INC
|
COO |
Sell |
5.0
|
-23,046
|
-25.28%
|
✓
|
$2.2M |
| May 4, 2015 |
May 5, 2015 |
Viking Therapeutics, Inc.
|
Director |
Buy |
95.0
|
+6,250
|
100.00%
|
✗
|
$50K |
| Dec 31, 2014 |
Jan 5, 2015 |
LIGAND PHARMACEUTICALS INC
|
COO |
Buy |
55.0
|
+46
|
0.08%
|
✗
|
$2.1K |
| Oct 10, 2014 |
Oct 14, 2014 |
LIGAND PHARMACEUTICALS INC
|
COO |
Buy |
55.0
|
+85
|
0.16%
|
✗
|
$3.8K |
| Jun 30, 2014 |
Jul 1, 2014 |
LIGAND PHARMACEUTICALS INC
|
COO |
Buy |
68.8
|
+428
|
0.80%
|
✗
|
$18.7K |
| Feb 12, 2014 |
Feb 14, 2014 |
LIGAND PHARMACEUTICALS INC
|
COO |
Sell |
20.0
|
-17,500
|
-14.47%
|
✓
|
$1.8M |